Skip to main content
Top
Published in: BMC Urology 1/2021

Open Access 01-12-2021 | Research article

Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics

Authors: Toby Page, Rajan Veeratterapillay, Kim Keltie, Julie Burn, Andrew Sims

Published in: BMC Urology | Issue 1/2021

Login to get access

Abstract

Background

To determine real-world outcomes of prostatic urethral lift (UroLift) procedures conducted in hospitals across England.

Methods

A retrospective observational cohort was identified from Hospital Episode Statistics data including men undergoing UroLift in hospitals in England between 2017 and 2020. Procedure uptake, patient demographics, inpatient complications, 30-day accident and emergency re-attendance rate, requirement for further treatment and catheterization were captured. Kaplan–Meier and hazard analysis were used to analyse time to re-treatment.

Results

2942 index UroLift procedures from 80 hospital trusts were analysed; 85.3% conducted as day-case surgery (admitted to hospital for a planned surgical procedure and returning home on the same day). In-hospital complication rate was 3.4%. 93% of men were catheter-free at 30 days. The acute accident and emergency attendance rate within 30 days was 12.0%. Results of Kaplan Meier analysis for subsequent re-treatment (including additional UroLift and endoscopic intervention) at 1 and 2 years were 5.2% [95% CI 4.2 to 6.1] and 11.9% [10.1 to 13.6] respectively.

Conclusions

This real-world analysis of UroLift shows that it can be delivered safely in a day-case setting with minimal morbidity. However, hospital resource usage for catheterization and emergency hospital attendance in the first 30 days was substantial, and 12% required re-treatment at 2 years.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study. J Urol. 2013;190(6):2161–7.CrossRef Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study. J Urol. 2013;190(6):2161–7.CrossRef
2.
go back to reference Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017;119(5):767–75.CrossRef Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017;119(5):767–75.CrossRef
3.
go back to reference Joshi H, Sali G, Paramore L, et al. Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we?—results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United Kingdom. Scott Med J. 2021;17:36933020977295. https://doi.org/10.1177/0036933020977295.CrossRef Joshi H, Sali G, Paramore L, et al. Current process and outcomes of the surgical management of LUTS due to benign prostatic enlargement: how consistent are we?—results from the multi-institutional audit of surgical management of BPE (AuSuM BPE) in the United Kingdom. Scott Med J. 2021;17:36933020977295. https://​doi.​org/​10.​1177/​0036933020977295​.CrossRef
4.
go back to reference Sonksen J, Barber N, Speakman M, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643–52.CrossRef Sonksen J, Barber N, Speakman M, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643–52.CrossRef
7.
go back to reference Rukstalis D, Grier D, Stroup SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22(3):411–9.CrossRef Rukstalis D, Grier D, Stroup SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22(3):411–9.CrossRef
8.
go back to reference Shah BB, Tayon K, Madiraju S, et al. Prostatic Urethral Lift: does size matter? J Endourol. 2018;32(7):635–8.CrossRef Shah BB, Tayon K, Madiraju S, et al. Prostatic Urethral Lift: does size matter? J Endourol. 2018;32(7):635–8.CrossRef
11.
go back to reference Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol. 2017;46(4):1093–1093i.CrossRef Herbert A, Wijlaars L, Zylbersztejn A, Cromwell D, Hardelid P. Data resource profile: hospital episode statistics admitted patient care (HES APC). Int J Epidemiol. 2017;46(4):1093–1093i.CrossRef
12.
go back to reference Keltie K, Donne A, Daniel M, et al. Paediatric tonsillectomy in England: a cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008–2019). Clin Otolaryngol. 2021;00:1–10. Keltie K, Donne A, Daniel M, et al. Paediatric tonsillectomy in England: a cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008–2019). Clin Otolaryngol. 2021;00:1–10.
14.
go back to reference Aylin P, Tanna S, Bottle A, Jarman B. Dr Foster’s case notes: how often are adverse events reported in English hospital statistics? BMJ. 2004;329(7462):369.CrossRef Aylin P, Tanna S, Bottle A, Jarman B. Dr Foster’s case notes: how often are adverse events reported in English hospital statistics? BMJ. 2004;329(7462):369.CrossRef
16.
go back to reference Eure G, Gange S, Walter P, et al. Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study. J Endourol. 2019;33(7):576–84.CrossRef Eure G, Gange S, Walter P, et al. Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study. J Endourol. 2019;33(7):576–84.CrossRef
17.
go back to reference Jones P, Rai BP, Aboumarzouk O, Somani BK. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol. 2016;8(6):372–6.CrossRef Jones P, Rai BP, Aboumarzouk O, Somani BK. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol. 2016;8(6):372–6.CrossRef
18.
go back to reference Roehrborn CG, Gange SN, Shore ND, et al. Durability of the Prostatic Urethral Lift: 2-year results of the L.I.F.T. study. Urol Pract. 2015;2:1–7.CrossRef Roehrborn CG, Gange SN, Shore ND, et al. Durability of the Prostatic Urethral Lift: 2-year results of the L.I.F.T. study. Urol Pract. 2015;2:1–7.CrossRef
19.
go back to reference Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015;22(3):7772–82.PubMed Roehrborn CG, Rukstalis DB, Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015;22(3):7772–82.PubMed
Metadata
Title
Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics
Authors
Toby Page
Rajan Veeratterapillay
Kim Keltie
Julie Burn
Andrew Sims
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2021
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-021-00824-5

Other articles of this Issue 1/2021

BMC Urology 1/2021 Go to the issue